MODULE 2.5: CLINICAL OVERVIEW
Phase 1 First-in-Human Study of TestDrug-001
Protocol Summary: Single and multiple ascending dose study in healthy volunteers
Primary Endpoint: Safety and tolerability
Secondary Endpoints: Pharmacokinetics, food effect
